Introduction
Carotid sinus syndrome (CSS) has recently emerged as a cause of unexplained syncope and falls in older subjects. The different types of CSS (cardioinhibitory, vasodepressor and 'mixed') can be diagnosed by performing a standardised carotid sinus massage (CSM) test under controlled conditions. Diagnosing the condition is important because interventions can successfully abolish symptoms. As well as general advice such as avoiding tight collars and sudden neck turning movements, dual chamber pacemakers are the treatment of choice for the cardioinhibitory and 'mixed' types of CSS and pharmacological treatments can be tried for the vasodepressor type CSS. The aim of this study was to assess the positive yield of CSM in different patient groups (unexplained syncope, falls and dizziness), as well as in a control group of asymptomatic subjects.
Methods
A consecutive group of patients aged G60 years with either syncope, falls or dizziness, the causes of which were unexplained (after a full history, examination, postural blood pressure measurements, routine blood tests, 12 lead ECG and 24 hour Holter monitoring) were recruited. Fallers had no definite history of syncope and subjects with dizziness had no definite history of syncope or falls. A control group of asymptomatic subjects aged G60 years were also recruited from a General Practice age-sex register. Subjects with a history of stroke disease, or with signs of aortic stenosis or carotid bruits were excluded. Continuous electrocardiography using a cardiac monitor and beat-to-beat blood pressure monitoring using digital plethysmography [Finapress] were performed. In the presence of resuscitation and external pacing equipment, CSM was performed in the supine position for 5 seconds separately on both sides. The procedure was repeated in the upright position with the subject strapped to a tilt table.
Cardioinhibitory CSS (CI-CSS) was defined as a period of asystole for G3 seconds, vasodepressor CSS (VD-CSS) was defined as a 50 mmHg systolic blood pressure drop [without a 3 seconds pause] (or 30 mmHg with symptoms) and ''mixed'' CSS was diagnosed if there was evidence for both.
Results
222 subjects (130 women, 92 men) in total were studied [mean age = 78.1, range = 60-96 years]. 178 of the subjects were symptomatic (syncope = 101, falls = 30, dizziness = 47) and 44 were asymptomatic controls. The type of subject by CSM response is shown in the table. Overall, any type of CSS was present in 27.7% (n = 28) of syncope subjects, 13.3% (n = 4) of fallers and 14.9% (n = 7) of dizziness subjects, compared to none of the control subjects [x 2 = 17.2, P = 0.001]. None of the subject had any adverse outcome after the test was finished.
Conclusions
CSM under controlled conditions is a useful test which can diagnose CSS in patients with unexplained syncope, falls or dizziness. The positive yield of CSM in unexplained syncope patients was almost 28% and was approximately twice that in patients with unexplained falls or dizziness. Unexplained syncope patients, in particular therefore, should be targeted for CSM. It is possible that in the unexplained fallers and dizziness patients the positive responses to CSM occurred in those patients who had no memory of previous syncopal episodes and this requires further study.
